Dhanvantri Jeevan Rekha Share Price Today | Stock Price & Dhanvantri Jeevan Rekha Share Screener
As of November 18, 2026, the live Dhanvantri Jeevan Rekha share price (BSE: ZDHJERK) is ₹22.20, up 0.23% from the previous close, with shares trading between ₹22.20 and ₹23.25 in today's trading session, and a 52-week range of ₹19.53–₹28.90. Track ZDHJERK market cap trends to gauge the company's total market size. Use the Dhanvantri Jeevan Rekha stock screener below to analyse P/E ratio, market cap, quarterly results, and more. See at what price today Dhanvantri Jeevan Rekha opened, then compare its market price and price volume with top gainers and top losers on the exchange. Record your trades in TickJournal's free trading journal and track your portfolio performance.
Key Statistics and Valuation Ratios
Over the trailing twelve months the company reported revenue of ₹31 and net income of ₹1, with EBITDA of ₹2, an operating margin of 4.0% and a profit margin of 3.2%.
Dhanvantri Jeevan Rekha Share Price Chart
Track the current stock price of Dhanvantri Jeevan Rekha with an interactive chart. Analyse ZDHJERK share price trends, closing price, trading volume, historical performance, and volatility using live market data across different timeframes, from the last 30 days to the full record — the complete Dhanvantri Jeevan Rekha stock quote in one place.
The quote of ₹22.20 sits between the 52-week low of ₹19.53 and the 52-week high of ₹28.90, and the latest session moved 0.23% from the previous close.
Dhanvantri Jeevan Rekha Company Profile - Fundamental Screener
Screen Dhanvantri Jeevan Rekha company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for ZDHJERK shares across the equity market and its stock price history, plus the wider market trend.
The company is classified under the Healthcare sector and the Healthcare Services industry, and it trades under ISIN INE239F01015.
Company Details
Classification
Identifiers and Leadership
Dhanvantri Jeevan Rekha Balance Sheet Screener
Screen ZDHJERK balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics, then compare equity shares and the debt-to-equity rate against peers in the stock market.
For 2026, total assets were ₹18, up from ₹15 in 2025.
Latest statistics put total assets at ₹18 and shareholder funds at ₹11.
| Item | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
Assets |
||||||||||
| Total Assets | 18 | 15 | 15 | 14 | 14 | 14 | 15 | 15 | 16 | 16 |
| Current Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Fixed Assets | 9 | 8 | 8 | 9 | 9 | 10 | 11 | 11 | 12 | 12 |
Liabilities |
||||||||||
| Total Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Liabilities | 2 | 2 | 2 | 2 | 2 | 2 | 1 | 1 | 3 | 3 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Shareholders' Equity |
||||||||||
| Total Equity | 11 | 10 | 10 | 9 | 10 | 9 | 11 | 11 | 11 | 10 |
| Share Capital | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 |
| Reserves & Surplus | 6 | 6 | 5 | 5 | 5 | 5 | 6 | 7 | 7 | 6 |
Dhanvantri Jeevan Rekha Income Statement Screener - Profit & Revenue Analysis
Screen Dhanvantri Jeevan Rekha income statement and profit fundamentals. Analyze ZDHJERK quarterly results. Dhanvantri Jeevan Rekha reports revenue growth, EBITDA, net profit margins, and EPS, and TickJournal's fundamental screener helps with stock evaluation and equity returns.
For None-None, revenue was ₹31 and net profit was ₹1, equal to earnings per unit of ₹1.90, at an operating margin of 4%.
In that period expenses were ₹30, interest cost ₹0 and tax ₹0. The next period listed, 2026-March, shows revenue of ₹26 and net profit of ₹0.
| Item | None-None | 2026-March | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March | 2016-March | 2015-March |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue and Expenses | |||||||||||||
| Revenue | 31 | 26 | 23 | 21 | 18 | 17 | 10 | 18 | 17 | 14 | 12 | 10 | 8 |
| Expenses | 30 | 25 | 22 | 20 | 17 | 15 | 11 | 18 | 16 | 12 | 10 | 8 | 7 |
Operating Costs and Margins | |||||||||||||
| EBITDA | 2 | 1 | 1 | 1 | 1 | 2 | -1 | 1 | 1 | 2 | 2 | 2 | 2 |
| Operating Profit % | 4.00% | 3.00% | 3.00% | 4.00% | 3.00% | 9.00% | -8.00% | 4.00% | 7.00% | 13.00% | 11.00% | 16.00% | 19.00% |
| Depreciation | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Profit and Earnings | |||||||||||||
| Profit Before Tax | 1 | 0 | 1 | 0 | 0 | 1 | -2 | 0 | 0 | 1 | 1 | 1 | 2 |
| Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 |
| Net Profit | 1 | 0 | 1 | 0 | 0 | 1 | -1 | 0 | 0 | 1 | 1 | 1 | 1 |
| EPS | 1.90 | 0.95 | 1.23 | 0.40 | -0.53 | 1.20 | -3.38 | -0.64 | 0.11 | 1.78 | 1.33 | 2.33 | 2.61 |
Dhanvantri Jeevan Rekha Cash Flow Screener - Liquidity Fundamentals
Screen ZDHJERK cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength and price trend assessment against the wider stock market and other stocks.
In 2026-March, operating activities generated ₹2, and net cash flow was an inflow of ₹1.
Over the same period, investing activities used ₹1 and financing activities provided ₹0.
| Item | 2026-March | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March |
|---|---|---|---|---|---|---|---|---|---|---|
Cash from Operations and Investing | ||||||||||
| Operating Activities | 2 | 0 | 3 | 0 | 1 | 0 | 1 | 1 | 1 | 4 |
| Investing Activities | -1 | -1 | 0 | -1 | 0 | 0 | 0 | 0 | -1 | -4 |
Financing and Net Cash | ||||||||||
| Financing Activities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -2 | 0 | 1 |
| Net Cash Flow | 1 | -1 | 3 | -1 | 1 | 0 | 1 | -1 | 0 | 0 |
Dhanvantri Jeevan Rekha Shareholding Pattern Screener
See Dhanvantri Jeevan Rekha shareholding pattern with promoter, FII, and DII holdings. Check Dhanvantri Jeevan Rekha promoter holding and ownership changes for ZDHJERK on TickJournal, and see how institutional stock price moves affect the market.
In 2026-Mar, promoters held 19.65%, foreign institutions 0.00%, domestic institutions 0.00% and the public 50.67%, spread across 1,682 shareholders.
The shareholder count was 1,682 in 2026-Mar, compared with 1,688 in 2026-Jun.
| Item | 2026-Mar | 2026-Jun | 2026-Sept | 2025-Mar | 2025-Jun | 2025-Sept | 2025-Dec | 2024-Mar |
|---|---|---|---|---|---|---|---|---|
Promoter Holding | ||||||||
| Promoter Holding | 19.65% | 19.65% | 19.65% | 19.65% | 19.65% | 19.65% | 19.65% | 19.65% |
Institutional Investors | ||||||||
| FII Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| DII Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Government, Public and Others | ||||||||
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 50.67% | 50.73% | 50.56% | 42.34% | 42.37% | 43.43% | 43.88% | 41.27% |
| Other Holding | 29.69% | 29.63% | 29.79% | 38.02% | 37.99% | 36.92% | 36.47% | 39.09% |
| Shareholder Count | 1,682 | 1,688 | 1,698 | 1,680 | 1,677 | 1,665 | 1,680 | 1,478 |
Dividend Yield Screener - Share Price & Share Analysis
Check the dividend history with payout and yield data. View dividend details including ex-dates, the dividend rate, and amounts paid by Dhanvantri Jeevan Rekha. Dhanvantri Jeevan Rekha dividend yield can be compared with peers and other stocks in the market.
Dhanvantri Jeevan Rekha Stock Index Membership - Nifty & Sensex
See which indices include Dhanvantri Jeevan Rekha stock. Check ZDHJERK index membership in NIFTY 50, SENSEX, and other indices on TickJournal, and compare the Nifty trend with the broader market trend.
Complete Index List
Dhanvantri Jeevan Rekha Market Events Screener - Corporate Actions
Get Dhanvantri Jeevan Rekha corporate actions including splits, bonuses, and buybacks disclosed to the exchange. Check Dhanvantri Jeevan Rekha stock events that may affect ZDHJERK share price, along with derivatives, futures and options activity and sector gainers.
12 corporate actions are listed, the most recent entry being Quarterly Result Announcement dated November 13, 2026, with a record date of November 13, 2026.
It is followed by Annual General Meeting dated September 29, 2026 and Quarterly Result Announcement dated August 13, 2026.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| 2026-11-13 | 2026-11-13 | Quarterly Result Announcement | NA | 5.69% |
| 2026-09-29 | 2026-09-29 | Annual General Meeting | NA | 0.35% |
| 2026-08-13 | 2026-08-13 | Quarterly Result Announcement | NA | 7.96% |
| 2026-05-28 | 2026-05-28 | Quarterly Result Announcement | NA | 0.87% |
| 2026-02-12 | 2026-02-12 | Quarterly Result Announcement | NA | 5.26% |
| 2025-11-14 | 2025-11-14 | Quarterly Result Announcement | NA | -5.52% |
| 2025-09-29 | 2025-09-29 | Annual General Meeting | NA | 38.42% |
| 2025-08-13 | 2025-08-13 | Quarterly Result Announcement | NA | -3.39% |
| 2025-05-30 | 2025-05-30 | Quarterly Result Announcement | NA | -2.05% |
| 2025-02-13 | 2025-02-13 | Quarterly Result Announcement | NA | -4.81% |
| 2024-11-14 | 2024-11-14 | Quarterly Result Announcement | NA | -5.67% |
| 2024-09-25 | 2024-09-25 | Annual General Meeting | NA | -11.40% |
Dhanvantri Jeevan Rekha Competitors Screener - Peer Stocks Comparison
Screen ZDHJERK competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance, from valuation and price target to the future price outlook, for better stock selection in a changing stock market.
The comparison table covers 10 companies in the Healthcare sector, shown with market capitalisation, P/E ratio, revenue, growth, net profit and RSI.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Apollo Hospitals | 125,416 | 52.40 | 25,420 | 15.58% | 2,003 | 57.80 |
| Max Healthcare Institute | 97,132 | 66.60 | 8,536 | 18.82% | 1,442 | 62.55 |
| Manipal Health Enterprises | 91,557 | 98.70 | 10,521 | 25.80% | 917 | 55.29 |
| Aster DM Quality Care | 65,615 | 111.60 | 4,769 | 11.25% | 427 | 54.92 |
| Fortis Healthcare | 60,283 | 54.40 | 9,179 | 16.93% | 1,064 | 46.04 |
| Global Health | 38,607 | 63.80 | 4,509 | 19.56% | 554 | 68.03 |
| Narayana Hrudayalaya | 38,493 | 44.30 | 7,996 | 43.43% | 811 | 56.24 |
| Dr. Lal Path Labs | 33,395 | 56.90 | 2,864 | 12.11% | 510 | 56.83 |
| Krishna Institute of Medical Sciences | 31,851 | 155.60 | 3,931 | 28.16% | 242 | 54.48 |
| Syngene International | 17,675 | 96.50 | 3,809 | 2.56% | 317 | 68.00 |
Dhanvantri Jeevan Rekha Company Announcements - News & Reports Screener
Screen ZDHJERK latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis, and review the option chain for related stocks. Compare other stocks in the same sector.
20 recent announcements are listed, the latest dated November 18, 2026.
The next most recent announcements are dated November 17, 2026 and November 17, 2026.
| Date | Update | Actions |
|---|---|---|
| 2026-11-18 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-11-17 | Result | - |
| 2026-11-17 | Board Meeting Outcome for Quarterly Result | - |
| 2026-11-10 | Board Meeting Intimation for Board Meeting Intimation | - |
| 2026-10-15 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | - |
| 2026-10-01 | Closure of Trading Window | - |
| 2026-09-29 | Shareholder Meeting / Postal Ballot-Outcome of AGM | - |
| 2026-09-07 | Reg. 34 (1) Annual Report. | - |
| 2026-09-05 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-09-05 | Reg. 34 (1) Annual Report. | - |
| 2026-09-04 | Shareholder Meeting Will Be Held At 29Th Sept 2026 At 3:00 PM | - |
| 2026-08-29 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-08-27 | Record Date As Per AGM | - |
| 2026-08-27 | Book Closure In Respect Of AGM | - |
| 2026-08-27 | Board Meeting Outcome for Outcome Of The Board Meeting | - |
| 2026-08-19 | Board Meeting Intimation for Board Meeting To Held On 27Th Aug For The Purpose Of Calling AGM | - |
| 2026-08-15 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-08-13 | Result For The Quarter Ending 30.06.2026 | - |
| 2026-08-13 | Board Meeting Outcome for Outcome Of The Board Meeting 13-08-2026 | - |
| 2026-08-06 | Board Meeting Intimation for The Board Meeting Is Schedule For 13.08.2026 | - |
Frequently Asked Questions
How is the company valued right now?
The current quote is ₹22.20, within a 52-week range of ₹19.53 to ₹28.90. The P/E ratio is 17.80 and the P/B ratio is 0.86, with earnings per unit of ₹0.95. Market capitalisation stands at ₹9.40 Cr. The company operates in the Healthcare sector, in the Healthcare Services industry, so compare these ratios with its sector peers in the table above.
About This Data
Quotes are sourced from the BSE. Key statistics were last updated on November 19, 2026. This page covers 10 balance sheet periods, 13 income statement periods, 10 cash flow years and 8 shareholding periods. Information is provided for research and is not investment advice.